Mild and Rapidly Improving Stroke Study (MaRISS)

University of Miami

Status: Completed

Conditions: Ischemic Stroke

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02072681

20120079

Details and patient eligibility

About

The objective of this study is to determine the 90-day outcomes of mild and rapidly improving ischemic stroke.

Enrollment: 2,175 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Mild or spontaneously rapidly improving ischemic stroke confirmed by neuroimaging
• Arrival to hospital within 4.5 hours of symptom onset
• Willing to provide consent
• Available for a telephone interview at 30 and 90 days

Exclusion criteria

• Onset >4.5 hours
• Unable to provide informed consent (patient or legally appointed representative
• Premorbid modified Rankin Scale >1
• Unavailable by telephone for follow-up

Trial design

2,175 participants in 1 patient group

Mild and Rapidly Improving Ischemic Stroke

Description:

Patients 18 years or older with mild or rapidly improving acute ischemic stroke defined clinically. .Absence of non-ischemic conditions neuro-imaging (i.e. absence of hemorrhage or a mass on brain imaging that arrived to the hospital within 4.5 hours after the onset of stroke symptoms. All participants will have two follow up telephone calls: One at approximately 30 days after the stroke and one at approximately 90 days after the stroke to ask questions about how well participant can carry out usual duties after the stroke, how much assistance do he/she needs to perform your daily activities and how good or bad would he/she considers current health to be.